← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2008Last known activity
Sep 18, 2017
Acquired by Acorda Therapeutics on Jan 19, 2016
Timeline
1990s
- Jan 1, 1992
Biotie Therapies— Founded
2000s
- Jan 1, 2002
Carbion, Inc.— Acquired
- Jan 1, 2002
Oy Contral Pharma Ltd— Acquired
- Jan 1, 2008
elbion— Acquired
2010s
- Jan 11, 2011
Synosia Therapeutics— Acquired
- Jan 19, 2016
Acorda Therapeutics— Acquired By
Drugs by trial phase (13 distinct, 18 trials)
Phase 3 (1 own, 1 via acquisition)
Phase 2 (6 own, 3 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (23)
- NCT03200080Lead sponsorPhase 1Sep 18, 2017
- NCT03212313Lead sponsorPhase 1Jun 30, 2017
- NCT03051607Lead sponsorPhase 3Apr 30, 2017
- NCT03051607Study directorPhase 3Apr 30, 2017
- NCT02239211CollaboratorPhase 2Sep 8, 2015
- NCT02453386Lead sponsorPhase 3Jul 1, 2015
- NCT02258152Lead sponsorPhase 2Dec 1, 2014
- NCT02240290Lead sponsorPhase 1Sep 1, 2013
- NCT01283594Study chairPhase 2/Phase 3Mar 1, 2011
- NCT01283594Study directorPhase 2/Phase 3Mar 1, 2011
- NCT01283594Lead sponsorPhase 2/Phase 3Mar 1, 2011
- NCT00977886Lead sponsorPhase 1Sep 1, 2009
- NCT00977886Study directorPhase 1Sep 1, 2009
- NCT00659230CollaboratorPhase 2Jul 1, 2009
- NCT00871598Lead sponsorPhase 1Mar 1, 2009
Details
- Founded
- Turku, FI Jan 1, 1992
- Last known activity
- Sep 18, 2017